1ER CLUSTER PHARMACEUTIQUE EN EUROPE. LE RESEAU D’EXCELLENCE ET D’INNOVATION DE LA FILIERE SANTE. MADE IN FRANCE.

Journées POLEPHARMA du Biotesting -2ème édition
11-12 & 18-19 mars 2021

#Stratégies analytiques pour accélérer le développement des biothérapies

PathoQuest

Partenaire Gold

En savoir plus

YOUR GENOMIC EXPERT FOR BIOLOGICS TESTING

Robust and efficient Quality Control testing is critical for the development of biologics in order to reduce time to market and improve patient outcomes.
Developers and producers need QC testing solutions that help de-risk their product development pipeline by preventing adventitious agent contamination and cell line misidentification.
To meet those objectives, PathoQuest offers advanced Next Generation Sequencing (NGS) solutions that supplement or replace traditional methods and support the strategic decision-making process. This innovative approach allows for a robust and unambiguous level of testing and for faster turnaround time and is available with GLP grade.

PATHOQUEST NGS SOLUTIONS IN 5 QUICK FACTS:

  1. PathoQuest is a French biotech based in Paris and soon a US based site in Pennsylvania
  2. It was created in 2010 as Spin-off of Institut Pasteur 
  3. The company has developed NGS applications for the QC of biological drugs (ATMP, Vaccines, antibodies…) allowing robust and fast analysis under GLP grade.
  4. PathoQuest has signed in 2018 a strategic partnership with Charles River Lab (Boston, USA).
  5. The company provides its services to more than 40 customers worldwide (Biotech, Pharma and CDMO)
 

Request the full brochure at welcome@pathoquest.com

PathoQuest: Fast and Validated Solutions for QC testing

Keen on learning more about challenges for adventitious virus detection and how standardized NGS method is the solution for the qualification of your biological production?

PathoQuest offers advanced Next Generation Sequencing (NGS) solutions that supplement or replace traditional methods and support the strategic decision-making process.

OUR SERVICES

VIRAL SAFETY
PathoQuest’s NGS-based adventitious virus testing approach uses a process called metagenomics to provide sensitive and comprehensive services for the identification of pathogens.

GENETIC CHARACTERIZATION
PathoQuest’s NGS-based genetic characterization testing approach uses the power and robustness of high-throughput sequencing to provide a comprehensive approach to the characterization of biologics intermediates, vaccines, and cell & gene therapy products.

COMPREHENSIVE QUALITY CONTROL FOR BIOLOGICS

PathoQuest NGS innovative approach provides biotech and biopharma companies developing advanced therapy medicinal products (ATMPs), vaccines and other biologicals with robust and unambiguous level of testing and with faster turnaround time.

OUR EXPERTS
Greater detection for better decisions

OUR SERVICE
Customized, fast, reliable, cost-effective

 

YOUR PRODUCTS 

VACCINES
– Broad range detection of viruses
– Genetic drift of vaccine stocks
– Assess highly concentrated stocks

BIOLOGICS
– Trancriptomic NGS approach on MCB
– Reduce the risk of false positives
–  Identity & Clonality documentation

GENE & CELL THERAPY
– Signature of viral replication
– High precision genetic characterization
– Insertion site / flanking regions sequencing

YOUR BENEFIT
Ensure the highest safety for your biologic products by de risking the drug development pipeline.

Contactez-nous





    Nos réseaux sociaux

    Contactez-nous








      Nos réseaux sociaux

      Polepharma a pour rôle de stimuler le développement économique et industriel des acteurs de la première filière pharmaceutique française par des actions favorisant la compétitivité, l’Innovation et l’attractivité au bénéfice de l’emploi.

      POLEPHARMA
      5 avenue Marcel Proust
      28000 Chartres
      Tél. : +33 (0)2 37 20 99 90
      Mail : contact@polepharma.com
      Shopping Basket